Arena Pharmaceuticals Inc. has begun patient dosing in a Phase 1b multiple-ascending dose clinical trial of APD371, a selective agonist of the cannabinoid 2 (CB2) receptor. Read More »

Track and Trace requirements scheduled to go into effect Sunday have been delayed until March 1, according to a Thursday announcement from the Food and Drug Administration (FDA). Read More »

A study of records at New York University's Langone Medical Center determined that too many patients being treated for severe acne are being left on ineffective antibiotics for too long before being prescribed isotretinoin (also known by its former brand name Accutane). Read More »

Cigna and Central Florida Affordable Care LLC announced on Thursday a collaboration to lower costs while improving health care and patient experience under Cigna’s accountable care organizations program called Cigna Collaborative Care. Read More »